Chemoinformaics analysis of [(1R,2R,5R)-6,6-DIMETHYL-2-BICYCLO[3.1.1]HEPTANYL]METHANOL
Molecular Weight | 154.253 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 17 |
Exact Molecular Weight | 154.136 | nRing | 3 |
Solubility: LogS | -2.975 | nHRing | 0 |
Solubility: LogP | 1.675 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 29.5043 |
nHD | 1 | BPOL | 18.0577 |
QED | 0.504 |
Synth | 5.309 |
Natural Product Likeliness | 3.624 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.902 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.533 |
MDCK | 0.0000313 |
BBB | 0.101 |
PPB | 0.833962 |
VDSS | 0.529 |
FU | 0.145389 |
CYP1A2-inh | 0.026 |
CYP1A2-sub | 0.161 |
CYP2c19-inh | 0.018 |
CYP2c19-sub | 0.4 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.054 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.118 |
CYP3a4-inh | 0.191 |
CYP3a4-sub | 0.203 |
CL | 4.235 |
T12 | 0.817 |
hERG | 0.028 |
Ames | 0.047 |
ROA | 0.046 |
SkinSen | 0.126 |
Carcinogencity | 0.64 |
EI | 0.085 |
Respiratory | 0.845 |
NR-Aromatase | 0.795 |
Antiviral | No |
Prediction | 0.942817 |